153 related articles for article (PubMed ID: 36709747)
41. Chanarin-Dorfman syndrome in three siblings in a non-consanguineous family.
Gomez-Moyano E; Godoy-Diaz DJ; Ponce-Verdugo L; Sanz-Trelles A; Vera-Casaño A; Sierra-Salinas C
J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):157-9. PubMed ID: 25087691
[No Abstract] [Full Text] [Related]
42. Truncation of CGI-58 protein causes malformation of lamellar granules resulting in ichthyosis in Dorfman-Chanarin syndrome.
Akiyama M; Sawamura D; Nomura Y; Sugawara M; Shimizu H
J Invest Dermatol; 2003 Nov; 121(5):1029-34. PubMed ID: 14708602
[TBL] [Abstract][Full Text] [Related]
43. Barrier dysfunction and pathogenesis of neutral lipid storage disease with ichthyosis (Chanarin-Dorfman syndrome).
Demerjian M; Crumrine DA; Milstone LM; Williams ML; Elias PM
J Invest Dermatol; 2006 Sep; 126(9):2032-8. PubMed ID: 16741516
[TBL] [Abstract][Full Text] [Related]
44. Two cases of non-alcoholic fatty liver disease caused by biallelic ABHD5 mutations.
Adant I; Declercq M; Bird M; Bauters M; Boeckx N; Devriendt K; Cassiman D; Witters P
J Hepatol; 2020 May; 72(5):1030-1032. PubMed ID: 32107051
[No Abstract] [Full Text] [Related]
45. Chanarin-Dorfman syndrome: deficiency in CGI-58, a lipid droplet-bound coactivator of lipase.
Yamaguchi T; Osumi T
Biochim Biophys Acta; 2009 Jun; 1791(6):519-23. PubMed ID: 19061969
[TBL] [Abstract][Full Text] [Related]
46. Two new mutations of the ABHD5 gene in a new adult case of Chanarin Dorfman syndrome: an uncommon lipid storage disease.
Schleinitz N; Fischer J; Sanchez A; Veit V; Harle JR; Pelissier JF
Arch Dermatol; 2005 Jun; 141(6):798-800. PubMed ID: 15967942
[No Abstract] [Full Text] [Related]
47. Cerebral lipid accumulation in Chanarin-Dorfman Syndrome.
Huigen MC; van der Graaf M; Morava E; Dassel AC; van Steensel MA; Seyger MM; Wevers RA; Willemsen MA
Mol Genet Metab; 2015 Jan; 114(1):51-4. PubMed ID: 25468645
[TBL] [Abstract][Full Text] [Related]
48. Dorfman-Chanarin syndrome.
Chilkar S; Paikrao P; Shah I
Indian J Gastroenterol; 2012 Jun; 31(3):147-8. PubMed ID: 22798180
[No Abstract] [Full Text] [Related]
49. Chanarin-Dorfman syndrome.
Demir B; Sen A; Bilik L; Deveci U; Ozercan IH; Cicek D; Dogan Y
Clin Exp Dermatol; 2017 Aug; 42(6):699-701. PubMed ID: 28636073
[No Abstract] [Full Text] [Related]
50. Jordans' Anomaly as a Red Flag for Neutral Lipid Storage Diseases.
Safavi M; Vasei M; Motamed F
Fetal Pediatr Pathol; 2022 Jun; 41(3):526-528. PubMed ID: 33966594
[No Abstract] [Full Text] [Related]
51. Neutral lipid storage leads to acylceramide deficiency, likely contributing to the pathogenesis of Dorfman-Chanarin syndrome.
Uchida Y; Cho Y; Moradian S; Kim J; Nakajima K; Crumrine D; Park K; Ujihara M; Akiyama M; Shimizu H; Holleran WM; Sano S; Elias PM
J Invest Dermatol; 2010 Oct; 130(10):2497-9. PubMed ID: 20520629
[No Abstract] [Full Text] [Related]
52. Education and imaging. Hepatology: Chanarin-Dorfman syndrome, a rare cause of fatty liver and steatohepatitis.
Kazemi MH; Taghavi SA; Eshraghian A; Talebzadeh M; Hamidpour L
J Gastroenterol Hepatol; 2015 May; 30(5):803. PubMed ID: 25865863
[No Abstract] [Full Text] [Related]
53. The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene.
Reilich P; Horvath R; Krause S; Schramm N; Turnbull DM; Trenell M; Hollingsworth KG; Gorman GS; Hans VH; Reimann J; MacMillan A; Turner L; Schollen A; Witte G; Czermin B; Holinski-Feder E; Walter MC; Schoser B; Lochmüller H
J Neurol; 2011 Nov; 258(11):1987-97. PubMed ID: 21544567
[TBL] [Abstract][Full Text] [Related]
54. Critical roles for α/β hydrolase domain 5 (ABHD5)/comparative gene identification-58 (CGI-58) at the lipid droplet interface and beyond.
Brown AL; Mark Brown J
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Oct; 1862(10 Pt B):1233-1241. PubMed ID: 28827091
[TBL] [Abstract][Full Text] [Related]
55. Dorfman-Chanarin syndrome in a Turkish kindred: conductor diagnosis requires analysis of multiple eosinophils.
Wollenberg A; Geiger E; Schaller M; Wolff H
Acta Derm Venereol; 2000; 80(1):39-43. PubMed ID: 10721832
[TBL] [Abstract][Full Text] [Related]
56. Steatohepatitis and liver cirrhosis in Chanarin-Dorfman syndrome with a new ABDH5 mutation.
Cakmak E; Alagozlu H; Yonem O; Ataseven H; Citli S; Ozer H
Clin Res Hepatol Gastroenterol; 2012 Apr; 36(2):e34-7. PubMed ID: 22245374
[TBL] [Abstract][Full Text] [Related]
57. Vacuolated Leukocytes in the Peripheral Blood Smear of a Child with Chanarin-Dorfman Syndrome.
Akyay A; Demir Şahin F; Şen A
Turk J Haematol; 2020 Nov; 37(4):299-300. PubMed ID: 32517421
[No Abstract] [Full Text] [Related]
58. Tazarotene 0.015% Cream as a Potential Topical Agent for Management of Ichthyosis in Dorfman-Chanarin Syndrome.
Niculescu L; Ruini C; Srour J; Salzer S; Schönbuchner I; von Braunmühl T; Ruzicka T; Hohenleutner U; Giehl KA; Fischer J; Wollenberg A
Acta Derm Venereol; 2019 Mar; 99(3):345-346. PubMed ID: 30460372
[No Abstract] [Full Text] [Related]
59. Recurrent N209* ABHD5 mutation in two unreported families with Chanarin Dorfman Syndrome.
Tavian D; Durdu M; Angelini C; Torre E; Missaglia S
Eur J Transl Myol; 2021 May; 31(2):. PubMed ID: 33985321
[TBL] [Abstract][Full Text] [Related]
60. CGI-58/ABHD5 gene is mutated in Dorfman-Chanarin syndrome.
Caux F; Selma ZB; Laroche L; Prud'homme JF; Fischer J
Am J Med Genet A; 2004 Aug; 129A(2):214. PubMed ID: 15316960
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
